Wealthspire Advisors, LLC Moderna, Inc. Transaction History

Wealthspire Advisors, LLC

$7.78 Billion
Q2 2024

A detailed history of Wealthspire Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 2,605 shares of MRNA stock, worth $171,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,605

Previous 2,725 4.4%

Holding current value

$171,278

Previous $290,000 6.55%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$101.21 - $166.61 $12,145 - $19,993	-120 Reduced 4.4%	2,605 $309,000
Q1 2024 May 06, 2024	SELL	$85.37 - $115.44 $25,867 - $34,978	-303 Reduced 10.01%	2,725 $290,000
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $18,142 - $27,256	-261 Reduced 7.94%	3,028 $301,000
Q3 2023 Nov 06, 2023	BUY	$96.41 - $126.61 $149,049 - $195,739	1,546 Added 88.7%	3,289 $339,000
Q2 2023 Jul 31, 2023	BUY	$118.5 - $160.53 $50,836 - $68,867	429 Added 32.65%	1,743 $211,000
Q1 2023 May 09, 2023	SELL	$135.66 - $197.02 $67,287 - $97,721	-496 Reduced 27.4%	1,314 $201,000
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $214,267 - $380,172	1,810 New	1,810 $325,000
Q2 2022 Aug 09, 2022	SELL	$117.13 - $176.59 $137,627 - $207,493	-1,175 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $148,590 - $276,183	1,175 New	1,175 $202,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $130,523 - $212,998	-578 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $128,258 - $280,023	578 New	578 $222,000
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $372,841 - $674,392	-2,870 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $313,346 - $533,762	2,870 New	2,870 $376,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Moderna, Inc. Transaction History